Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...

"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...

Absci's recent strategic collaborations with Advanced Micro Devices (NASDAQ:AMD) and AstraZeneca (NASDAQ:AZN) were also spotlighted. The partnership with AMD, which includes a $20 million ...

Absci Corp. (NASDAQ:ABSI) shares, currently trading at $3.22, received a positive outlook from Needham as the firm began coverage with a Buy rating and set a price target of $9.00. The stock has shown ...

AstraZeneca has unveiled plans to invest around $570 million in Canada and add around 700 new jobs, describing the county as ...

Says Analyst Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside Carnival Corp's Private Island Strategy Poised For Significant Expansion, Says Analyst Analyst Praises ...

Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery. Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm ...

AMD has revealed the upcoming flagship Ryzen 9 9950X3D will offer ‘comparable’ performance-wise to the 9800X3D, widely regarded as one of the best gaming CPUs on the market. AMD Ryzen 9 ...

TL;DR: AMD has announced that its RDNA 4 desktop gaming GPUs, including the Radeon 9000 Series, will launch in March 2025. This timing follows NVIDIA's release of the GeForce RTX 5070 series ...

What a brutal six months it’s been for AMD. The stock has dropped 22% and now trades at $121.52, rattling many shareholders. This might have investors contemplating their next move. Following ...